Ortho Clinical Diagnostics and Sphingotec Announce Strategic Agreement Regarding Novel Biomarker for Decreasing Re-hospitalizations in Heart Failure
8 December 2017
Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, and sphingotec GmbH today announced a long-term, global strategic agreement regarding the endothelial function marker, b
